Children Nutrition Research Center (Houston, Tx) Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Children's Nutrition Research Center Research
Metabolic Research Unit
Body Composition Lab
Eating Behavior Laboratory
Energy Metabolism Lab
Plant Physiology Lab
Analytical Core Labs
 

Research Project: CHILDHOOD OBESITY: REGULATION OF ENERGY BALANCE AND BODY COMPOSITION

Location: Children Nutrition Research Center (Houston, Tx)

Title: APOLIPOPROTEIN E GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH DIABETIC RETINOPATHY: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY

Authors
item Liew, Gerald - UNIVERSITY OF SYDNEY
item Shankar, Anoop - NAT. UNIV. OF SINGAPORE
item Wang, Jie - UNIVERSITY OF SYDNEY
item Klein, Ronald - UNIVERSITY OF WISCONSIN
item Bray, Molly
item Couper, David - UNIVERSITY OF NORTH CAROL
item Wong, Tien - NAT. UNIV. OF SINGAPORE

Submitted to: Trade Journal Publication
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: February 11, 2006
Publication Date: July 2, 2006
Citation: Liew, G., Shankar, A., Wang, J.J., Klein, R., Bray, M.S., Couper, D.J., Wong, T.Y. 2006. Apolipoprotein E gene polymorphisms are not associated with diabetic retinopathy: The atherosclerosis risk in communities study. American Journal of Opthalmology. 142:105-111.

Interpretive Summary: We studied whether variation in the DNA sequence of the apolipoprotein E (APOE) gene was associated with diabetic retinopathy, a disease of the eyes associated with the development of diabetes. We studied 1,398 people aged 49 to 73 years with diabetes selected from four United States communities. We performed photography of the eye on one randomly selected eye and graded for the presence and severity of diabetic retinopathy. APOE gene variation was not associated with diabetic retinopathy in either Caucasians or African-Americans, but in African-Americans, one form of the gene was associated with hard fluids in the eye. These results suggest that APOE gene polymorphisms are not associated with diabetic retinopathy in either Caucasians or African-Americans with type 2 diabetes.

Technical Abstract: PURPOSE: Polymorphism of the apolipoprotein E (APOE) gene has been associated with dyslipidemia and cardiovascular disease. This study examines the association of APOE polymorphisms and diabetic retinopathy. DESIGN: Population-based cross-sectional study. METHODS: We studied 1,398 people aged 49 to 73 years with diabetes selected from four United States communities. We performed retinal photography on one randomly selected eye and graded for the presence and severity of diabetic retinopathy using a modification of the Early Treatment Diabetic Retinopathy Study scale. We performed genotyping of common polymorphic APOE alleles using polymerase chain reaction on genomic DNA from venous blood leukocytes. RESULTS: The prevalence of diabetic retinopathy and hard exudates was 15.0% and 5.3% in Caucasians (n = 935), and 24.6% and 9.7% in African-Americans (n = 463), with type 2 diabetes. APOE gene polymorphisms were not associated with diabetic retinopathy in either Caucasians or African-Americans. In African-Americans, the epsilon 2/epsilon 4 genotype (n = 6) was associated with increased prevalence of hard exudates (odds ratio [OR] 4.10, 95% confidence interval [CI] 1.30 to 12.90), as was the epsilon 2/epsilon 3 genotype (n = 9, OR 2.64, 95% CI 1.01 to 6.95). No association between APOE genotypes and hard exudates was found in Caucasians. CONCLUSIONS: These data suggest that APOE gene polymorphisms are not associated with diabetic retinopathy in either Caucasians or African-Americans with type 2 diabetes.

   

 
Project Team
Upchurch, Dan
 
Publications
   Publications
 
Related National Programs
  Human Nutrition (107)
 
 
Last Modified: 05/23/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House